Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?
A. Uusaro et Ja. Russell, Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?, INTEN CAR M, 26(3), 2000, pp. 299-304
Objective:To evaluate the literature regarding antiinflammatory actions of
cytokines, evaluate randomized controlled trials (RCTs) of supranormal oxyg
en delivery, and suggest alternative mechanism(s) for possible beneficial e
ffects of supranormal oxygen delivery in critically ill surgical patients.
Design: Literature review using Medline and review of selected illustrative
studies.
Main results: Catecholamines (epinephrine, norepinephrine, isoproterenol, a
nd dopamine) in general inhibit tumor necrosis factor-alpha (TNF) productio
n and may enhance interleukin-6 (IL-6) and IL-10 production. Phosphodiester
ase inhibitors also inhibit TNF and may enhance IL-10. All studies used mod
els (cell, animal, or humans infused with endotoxin) of sepsis. RCTs of sup
ranormal oxygen delivery show decreased mortality in high-risk surgical pat
ients; however, prevention or reversal of tissue hypoxia may not be the mec
hanism of benefit. Antiinflammatory effects of catecholamines are a potenti
al and, to date, unexplored mechanism of the benefit of supranormal oxygen
delivery in critically ill surgical patients.
Conclusions: Catecholamines may modulate cytokine response beneficially and
could be a mechanism of decreased morbidity and mortality of supranormal o
xygen delivery in high-risk surgical patients.